Work

Adjuvant enzalutamide (Enza) for men with high-risk prostate cancer (HRPCa) after radical prostatectomy (RP).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.5071

Authors: Moshe Chaim Ornstein, Andrew J. Stephenson, Paul Elson, Allison Janine Tyler, Pam Profusek, Petros Grivas, Brian I. Rini, Eric A. Klein, Jorge A. Garcia

Institution: Cleveland Clinic

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2474956782

Cites:

Cited by: 2

Related to: 10